11/14/2024
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
6:13 PM | Logos Global Management LP (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
6:01 PM | Unicycive Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/14/2024
3:53 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/13/2024
4:29 PM | Unicycive Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
|
11/13/2024
3:52 PM | Unicycive Therapeutics (Subject)
Walleye Capital LLC (Filed by)
| Form SC 13G | |
11/13/2024
3:05 PM | Unicycive Therapeutics (Filer)
| Form POS AM | |
11/13/2024
7:04 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
6:05 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:15 PM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:54 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:11 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:05 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024
3:10 PM | GREAT POINT PARTNERS LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G | |
07/16/2024
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
07/16/2024
9:31 AM | Unicycive Therapeutics (Filer)
| Form 424B3 | |
07/15/2024
3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
4:20 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
8:15 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:10 PM | Unicycive Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
4:11 PM | Unicycive Therapeutics (Filer)
| Form ARS | |
04/26/2024
4:12 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
04/17/2024
3:31 PM | Gupta Shalabh K. (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:31 PM | Gupta Pramod (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:32 PM | Jermasek Douglas (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:33 PM | Townsend John (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:06 PM | Unicycive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
4:09 PM | Unicycive Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/14/2024
5:41 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
2:18 PM | ARMISTICE CAPITAL, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
3:27 PM | Logos Global Management LP (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G | |
12/08/2023
3:36 PM | Unicycive Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
